LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $540,000 | -27.1% | 4,473 | -1.7% | 0.00% | – |
| Q4 2021 | $741,000 | -9.7% | 4,551 | -21.7% | 0.00% | – |
| Q3 2021 | $821,000 | +332.1% | 5,810 | +324.1% | 0.00% | – |
| Q2 2021 | $190,000 | -14.0% | 1,370 | -3.8% | 0.00% | – |
| Q1 2021 | $221,000 | -36.1% | 1,424 | -55.1% | 0.00% | – |
| Q4 2020 | $346,000 | +95.5% | 3,171 | +81.0% | 0.00% | – |
| Q3 2020 | $177,000 | -28.3% | 1,752 | -20.4% | 0.00% | – |
| Q2 2020 | $247,000 | +782.1% | 2,202 | +473.4% | 0.00% | – |
| Q1 2020 | $28,000 | -93.7% | 384 | -91.0% | 0.00% | – |
| Q4 2019 | $444,000 | +100.9% | 4,254 | +91.8% | 0.00% | – |
| Q3 2019 | $221,000 | -19.3% | 2,218 | -7.5% | 0.00% | – |
| Q2 2019 | $274,000 | +115.7% | 2,398 | +137.9% | 0.00% | – |
| Q1 2019 | $127,000 | -90.6% | 1,008 | -89.9% | 0.00% | -100.0% |
| Q4 2018 | $1,357,000 | -48.9% | 10,002 | +3.4% | 0.00% | -50.0% |
| Q3 2018 | $2,655,000 | +37.1% | 9,672 | +3.5% | 0.00% | 0.0% |
| Q2 2018 | $1,937,000 | +20.6% | 9,348 | -3.9% | 0.00% | +100.0% |
| Q1 2018 | $1,606,000 | +18.2% | 9,725 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $1,359,000 | +1219.4% | 9,922 | +1202.1% | 0.00% | – |
| Q3 2017 | $103,000 | -92.2% | 762 | -93.0% | 0.00% | -100.0% |
| Q2 2017 | $1,319,000 | -74.5% | 10,868 | -77.7% | 0.00% | -60.0% |
| Q1 2017 | $5,163,000 | +120.5% | 48,782 | +117.5% | 0.01% | +150.0% |
| Q4 2016 | $2,342,000 | -77.1% | 22,432 | -77.6% | 0.00% | -81.8% |
| Q3 2016 | $10,237,000 | +3301.0% | 100,314 | +3871.3% | 0.01% | – |
| Q2 2016 | $301,000 | -57.4% | 2,526 | -61.8% | 0.00% | -100.0% |
| Q1 2016 | $707,000 | +2.2% | 6,605 | +3.5% | 0.00% | 0.0% |
| Q4 2015 | $692,000 | +31.8% | 6,384 | +4.1% | 0.00% | 0.0% |
| Q3 2015 | $525,000 | -21.4% | 6,133 | -7.4% | 0.00% | 0.0% |
| Q2 2015 | $668,000 | +98.8% | 6,625 | +52.3% | 0.00% | – |
| Q1 2015 | $336,000 | +36.0% | 4,351 | -6.3% | 0.00% | – |
| Q4 2014 | $247,000 | +0.4% | 4,646 | -11.4% | 0.00% | – |
| Q3 2014 | $246,000 | +173.3% | 5,246 | +260.5% | 0.00% | – |
| Q2 2014 | $90,000 | +34.3% | 1,455 | +44.8% | 0.00% | – |
| Q1 2014 | $67,000 | +346.7% | 1,005 | +258.9% | 0.00% | – |
| Q4 2013 | $15,000 | -75.0% | 280 | -79.8% | 0.00% | – |
| Q3 2013 | $60,000 | +15.4% | 1,383 | 0.0% | 0.00% | – |
| Q2 2013 | $52,000 | – | 1,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |